AJG Series: Molecular Biology for Clinicians

Saito, Yuri A; Talley, Nicholas J
October 2009
American Journal of Gastroenterology;Oct2009, Vol. 104 Issue 10, p2583
Academic Journal
Pharmacogenetics is an evolving field that provides the link between an individual's genetic code and drug metabolism and drug response. This field offers the great promise of individualized medication selection and optimized dosage to maximize treatment response and to minimize adverse side effects. As our understanding of the role of the effects of genetic variants on drug metabolism and body drug processing grows, so does our ability to educate and inform our patients about expected treatment response to the medications being prescribed to them. This brief review will provide an overview of genetics, pharmacogenetics, and current and future examples of genetic variants predicting drug response in gastrointestinal disease, and the limitations and the promise of this exciting and developing field.


Related Articles

  • Pharmacogenomics and Personalized Use of Drugs. Jing-Fang Wang; Dong-Qing Wei; Kuo-Chen Chou // Current Topics in Medicinal Chemistry;Dec2008, Vol. 8 Issue 18, p1573 

    As the development of the Human Genome Project (HGP), the sequencing of whole human genome has been completed, and a series of human genes have been detected, both of which result in the naissance of pharmacogenomics. Pharmacogenomics is the study of how an individual's genetic inheritance...

  • Pharmacogenomics and Computational Genomics: An Appraisal. Tripathi, P. K.; Tripathi, Shalini; Jain, N. K. // Indian Journal of Pharmaceutical Sciences;2007, Vol. 69 Issue 1, p1 

    Pharmacogenomics deals with the interactions of individual genetic constitution with drug therapy. It is very likely that pharmacogenetic tests will make up a significant proportion of total molecular biology testing in future. Therefore, this article emphasizes the applications of...

  • Personalized and Predictive Medicine in Turkey: A Symposium Report of the Istanbul Working Group on Personalized Medicine, Istanbul, Turkey, September 10-12, 2009. Hizel, C.; Gök, S.; Sardas, S.; Bernard-Gallon, D.; Maugard, C.; Genç, E. // Current Pharmacogenomics & Personalized Medicine;2009, Vol. 7 Issue 4, p297 

    Pharmacogenetics has its roots in the 1950s with pioneering studies of monogenic variations in drug metabolism and pharmacokinetics. With the availability of high-throughput genomics technologies and the completion of the Human Genome Project in 2003, we are now in the postgenomics era. This...

  • Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Brockmöller, Jürgen; Tzvetkov, Mladen V. // European Journal of Clinical Pharmacology;Feb2008, Vol. 64 Issue 2, p133 

    Variation in the human genome is a most important cause of variable response to drugs and other xenobiotics. Susceptibility to almost all diseases is determined to some extent by genetic variation. Driven by the advances in molecular biology, pharmacogenetics has evolved within the past 40 years...

  • Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Zanger, Ulrich M.; Turpeinen, Miia; Klein, Kathrin; Schwab, Matthias // Analytical & Bioanalytical Chemistry;Nov2008, Vol. 392 Issue 6, p1093 

    We investigated the elimination routes for the 200 drugs that are sold most often by prescription count in the United States. The majority (78%) of the hepatically cleared drugs were found to be subject to oxidative metabolism via cytochromes P450 of the families 1, 2 and 3, with major...

  • Genomics in Cancer Care. Fessele, Kristen L. // ONS Connect;Oct2008, Vol. 23 Issue 10, p10 

    This article discusses many potential applications of genomic knowledge in cancer care. According to the article, some potential uses of genomic information include selecting the most effective cancer therapies and identifying patients who may be at risk for increased toxicity with a particular...

  • PHARMACOGENETICS: THE WAY TO PERSONALIZED MEDICINE. Cabaleiro, Teresa; Abad-Santos, Francisco // Electronic Journal of Biomedicine;2011, Issue 2, p3 

    The author reflects on the incorporation of pharmacogenetics in clinical research. He discusses the applications of pharmacogenetics in process of drug metabolism, genetic polymorphism and in genotypic analysis . He further states that patient genome would give more opportunities to physicians...

  • New England Journal of Medicine: Serious complication of gastrointestinal procedure can often be avoided with single dose medication.  // Biomedical Market Newsletter;4/14/2012, Vol. 21, p1 

    The article offers information on a study which revealed that the complications of gastrointestinal diagnosing procedure can be prevented with medication.

  • Possible clinical importance of genetic differences in drug metabolism. Nebert, Daniel W. // British Medical Journal (Clinical Research Edition);8/22/1981, Vol. 283 Issue 6290, p537 

    Examines the drug metabolism with the pharmacogenetic differences in Great Britain. Complication of the network pathway; Evaluation of the enzyme system; Oxidation by cytochrome P-450.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics